E. Gheuens

432 total citations
20 papers, 314 citations indexed

About

E. Gheuens is a scholar working on Oncology, Surgery and Emergency Medicine. According to data from OpenAlex, E. Gheuens has authored 20 papers receiving a total of 314 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 5 papers in Surgery and 4 papers in Emergency Medicine. Recurrent topics in E. Gheuens's work include Drug Transport and Resistance Mechanisms (7 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers) and Carcinogens and Genotoxicity Assessment (2 papers). E. Gheuens is often cited by papers focused on Drug Transport and Resistance Mechanisms (7 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers) and Carcinogens and Genotoxicity Assessment (2 papers). E. Gheuens collaborates with scholars based in Belgium, Netherlands and France. E. Gheuens's co-authors include E. A. de Bruijn, Pierre Zachée, R. Lins, Marc E. De Broe, Monique Elseviers, R. Daelemans, A. van Oosterom, R. Daelemans, Allan T. van Oosterom and A.T. van Oosterom and has published in prestigious journals such as Biochemical Pharmacology, Nephrology Dialysis Transplantation and Surgical Endoscopy.

In The Last Decade

E. Gheuens

20 papers receiving 308 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. Gheuens Belgium 11 125 93 89 72 72 20 314
Jesse Hall United States 12 150 1.2× 259 2.8× 124 1.4× 153 2.1× 57 0.8× 23 498
Rasha El‐Ashry Egypt 11 65 0.5× 32 0.3× 60 0.7× 38 0.5× 27 0.4× 24 297
Suzette C. Walker-Andrews United States 9 120 1.0× 29 0.3× 33 0.4× 157 2.2× 58 0.8× 13 484
Jur Strobos United States 13 16 0.1× 137 1.5× 56 0.6× 82 1.1× 20 0.3× 17 793
Alice Wolfromm France 6 24 0.2× 37 0.4× 60 0.7× 22 0.3× 38 0.5× 10 274
Kevin T. Sangster Canada 5 27 0.2× 96 1.0× 241 2.7× 75 1.0× 36 0.5× 5 529
Mya Thein United States 7 141 1.1× 23 0.2× 103 1.2× 15 0.2× 31 0.4× 13 450
Frank A. Corvino United States 10 83 0.7× 24 0.3× 74 0.8× 84 1.2× 66 0.9× 25 356
Nasir Hussain United States 11 69 0.6× 28 0.3× 43 0.5× 66 0.9× 39 0.5× 26 303
G. Pérez Manga Spain 8 233 1.9× 8 0.1× 79 0.9× 77 1.1× 20 0.3× 35 400

Countries citing papers authored by E. Gheuens

Since Specialization
Citations

This map shows the geographic impact of E. Gheuens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Gheuens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Gheuens more than expected).

Fields of papers citing papers by E. Gheuens

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Gheuens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Gheuens. The network helps show where E. Gheuens may publish in the future.

Co-authorship network of co-authors of E. Gheuens

This figure shows the co-authorship network connecting the top 25 collaborators of E. Gheuens. A scholar is included among the top collaborators of E. Gheuens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Gheuens. E. Gheuens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gheuens, E., et al.. (2014). Dialysability of Gadoteric Acid in Patients With End-Stage Renal Disease Undergoing Hemodialysis. Investigative Radiology. 49(8). 505–508. 23 indexed citations
2.
Florence, Éric, et al.. (2010). Prevalence of chronic renal failure stage 3 or more in HIV‐infected patients in Antwerp: an observational study. Journal of the International AIDS Society. 13(S4). 1 indexed citations
3.
Florence, Éric, et al.. (2010). PREVALENCE OF CHRONIC RENAL FAILURE STAGE 3 OR MORE IN HIV-INFECTED PATIENTS IN ANTWERP: AN OBSERVATIONAL STUDY. Acta Clinica Belgica. 65(6). 392–398. 5 indexed citations
4.
Lins, R., Monique Elseviers, R. Daelemans, et al.. (2004). Re-evaluation and modification of the Stuivenberg Hospital Acute Renal Failure (SHARF) scoring system for the prognosis of acute renal failure: an independent multicentre, prospective study. Nephrology Dialysis Transplantation. 19(9). 2282–2288. 52 indexed citations
5.
Totté, E., R. Van Hee, Bart Wollaert, et al.. (2002). Laparoscopic transabdominal pericardial window. Surgical Endoscopy. 16(5). 859–863. 8 indexed citations
6.
Lins, R., Monique Elseviers, R. Daelemans, et al.. (2000). Prognostic value of a new scoring system for hospital mortality in acute renal failure.. PubMed. 53(1). 10–7. 48 indexed citations
7.
Gheuens, E., et al.. (1997). Comparison of daunorubicin and Fluo-3 for detection of multidrug resistance in human tumor cells.. PubMed. 21(1). 78–82. 1 indexed citations
8.
Jorens, P. G., Frans J. van Overveld, Jan P. van Meerbeeck, et al.. (1996). Evidence for marked eosinophil degranulation in a case of eosinophilic pneumonia. Respiratory Medicine. 90(8). 505–509. 1 indexed citations
9.
Gheuens, E., et al.. (1995). P-Glycoprotein: Clinical Significance and Methods of Analysis. Critical Reviews in Clinical Laboratory Sciences. 32(3). 221–264. 37 indexed citations
10.
Gheuens, E., et al.. (1995). [In vitro effects of piracetam on the radiosensitivity of hypoxic cells (adaptation of MTT assay to hypoxic conditions)].. PubMed. 82(11). 929–38. 3 indexed citations
11.
Gheuens, E., Wim van de Vrie, Dirk Van Bockstaele, et al.. (1994). 5′‐Deoxy‐S‐fluorouridine Increases Daunorubicin Uptake in Multidrug‐resistant Cells and Its Activity Is Related with P‐gp 170 Expression. Japanese Journal of Cancer Research. 85(1). 13–16. 6 indexed citations
13.
Vrie, Wim van de, E. Gheuens, A. Bijma, et al.. (1993). Drug resistance in rat colon cancer cell lines is associated with minor changes in susceptibility to cytotoxic cells. Cancer Immunology Immunotherapy. 37(5). 337–342. 1 indexed citations
14.
Vrie, Wim van de, E. Gheuens, E. A. de Bruijn, et al.. (1993). In vitro and in vivo chemosensitizing effect of cyclosporin A on an intrinsic multidrug-resistant rat colon tumour. Journal of Cancer Research and Clinical Oncology. 119(10). 609–614. 18 indexed citations
15.
Gheuens, E., et al.. (1993). Multidrug Resistance in Rat Colon Carcinoma Cell Lines CC531, CC531mdr+ and CC531rev. Japanese Journal of Cancer Research. 84(11). 1201–1208. 13 indexed citations
16.
Bruijn, E. A. de, et al.. (1992). Fluorouracil Catabolism in the Combination Treatment of Cyclophosphamide, Methotrexate and Fluorouracil. Japanese Journal of Cancer Research. 83(10). 1102–1107. 1 indexed citations
17.
Gheuens, E., Dirk R. Van Bockstaele, Maarten van der Keur, et al.. (1991). Flow cytometric double labeling technique for screening of multidrug resistance. Cytometry. 12(7). 636–644. 36 indexed citations
18.
Gheuens, E., et al.. (1991). Activation and cytotoxicity of 5′-deoxy-5-fluorouridine in c-H-ras transformed NIH 3T3 cells. Biochemical Pharmacology. 41(2). 301–303. 10 indexed citations
19.
Scalliet, Pierre, et al.. (1991). Resistance patterns between cis-diamminedichloroplatinum(II) and ionizing radiation.. PubMed. 51(17). 4523–7. 29 indexed citations
20.
Gheuens, E., et al.. (1990). Bioavailability of Cyclophosphamide in the CMF Regimen. Oncology Research and Treatment. 13(3). 203–206. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026